Short description
Sensorion is a France-based biopharmaceutical company developing targeted therapeutic solutions for the treatment of vestibular deficits.
Description
Sensorion, a Clapiers, France-based biopharmaceutical company specifically dedicated to the development of innovative and targeted therapeutic solutions to treat vestibular deficits.
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Clapiers, Languedoc-Roussillon, France, Europe
Founded on
January 1, 2009
Exited on
April 30, 2015
Went public on
April 30, 2015
Stock symbol
ALSEN
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$56378 - 90123
Sign in for full access
Investors
Cannot Access, Blurry Noaccess, Absolutely Noaccess, Uh Ohhhh, Nopepepe, No Way, Uh Ohhhh
Sign in for full access
Founders
Christian Chabbert